Low HDL definition

Jump to navigation Jump to search

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

Low HDL definition On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Low HDL definition

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Low HDL definition

CDC on Low HDL definition

Low HDL definition in the news

Blogs on Low HDL definition

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for Low HDL definition

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Overview

Low HDL level cut-off point has been a debate in many surveys. Most recently, it was set to be below 1.0 mmol/L (40 mg/dL), both in men and women.[1]

Definition

Low HDL level cut-off point has been subjected recently to variable changes. In the Pan-European survey of HDL-cholesterol set out to determine the prevalence of low HDL-cholesterol, they defined the low HDL cut-off by levels below 1.03 mmol/L (40 mg/dL) in men, and 1.29 mmol/L (50 mg/dL)in women.[2] The clear risk of cardiovascular disease at levels above 35 mg/dL led the ATP III panel to recognize a higher cut-off for low HDL, they considered a level <40 mg/dL in both men and women. ATP III also rejected the idea to Set a different cut-point for low HDL cholesterol in men and women, and explained this rejection that it would make many women who are otherwise at low risk eligible for LDL-lowering drugs.[1]

References

  1. 1.0 1.1 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report". Circulation. 106 (25): 3143–421. PMID 12485966.
  2. "Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients". Retrieved 20 September 2013.


Template:WikiDoc Sources